We assessed the prevalence of latent tuberculosis infection (tuberculin skin test reactivity ≥10 mm), human immunodeficiency virus (HIV) and hepatitis B seropositivity, intestinal parasite test positivity, need for vaccinations, and time from date of US arrival to receipt of screening.
Since 1990, the United States has resettled >2 million persecuted persons from around the world. [1] The United States classifies these persons into 2 groups based on where they are located when they apply for asylum. Refugees are persons who apply for and are granted asylum status while outside the United States, and asylees are persons who apply for and are granted asylum while already present inside the United States.
US-resettling refugees, hereafter called refugees, number nearly 1.6 million since 1990 [1] and are at high risk for infectious diseases [2] . Prior to arrival, refugees are frequently housed in camps where medical care, nutrition, water, sanitation, and housing are often poor [3, 4] . To prevent spread of communicable disease, refugees are medically screened overseas before departure and shortly after US arrival. Overseas, refugees are laboratory screened for infectious tuberculosis and syphilis. Upon arrival, the Centers for Disease Control and Prevention (CDC) and the assigned state health department and humanitarian volunteer agency are notified. Volunteer agencies arrange for postarrival medical screening [5] and social services. No screening guidelines exist for other arriving groups owing to lack of disease burden data.
In contrast, US-located asylees, hereafter called asylees, number >450 000 since 1990 [1] and undergo minimal or no consistent medical screening before, during, or after they are granted asylum. Asylees enter the United States in multiple ways, including as tourists, students, or undocumented immigrants and usually enter as single individuals. When a person applies for or is granted asylum, the CDC and US states are not notified of their existence and humanitarian volunteer agencies are not regularly funded to support them.
Few studies studies have examined US asylee health [6] [7] [8] [9] [10] . Previous work has primarily considered either chronic diseases or mental health concerns related to past trauma, torture, or US detention; to our knowledge, no studies have examined infectious disease concerns.
Unlike many jurisdictions, the District of Columbia Department of Health (DCDOH) has accessed asylees in a unique way. DC asylees seeking social services are referred to DCDOH for a medical screening, which has allowed DCDOH to assess the health status of a US asylee population. Our study objectives were 2-fold: (1) to compare health status indicators and time to receipt of a medical screening of newly screened DC asylees with DC refugees, and (2) to compare health status indicators of DC asylees with the general US population into which they have resettled.
METHODS
We conducted a retrospective cohort study of persons with official US asylee or refugee status (clients) registered with DCDOH for a medical screening from 1 September 2003 to 31 August 2007. We excluded clients not completing a DCDOH-sponsored medical screening or initially resettling in another US location, to exclude previously screened clients, and family-sponsored asylees because they are prescreened overseas. Refugees assigned to DC for resettlement are required to undergo a medical screening through DCDOH, and therefore ascertainment of refugees was essentially complete. Because health departments of localities into which asylees resettle are not notified when asylum is granted, DCDOH could only screen asylees seeking social services and therefore our cohort of asylees comprises a convenience sample.
Asylees and refugees referred to DCDOH were offered the same medical screening that included a medical history, physical examination, laboratory testing for stool and blood samples, skin testing, vaccinations, treatment, and follow-up. Human subjects review at CDC determined this surveillance review to be nonresearch that did not require further review from an institutional review board.
Because parents can sponsor unmarried children aged <21 years to enter the United States, age groups were defined as children (aged <21 years) and adults (aged ≥21 years). Time from US arrival to medical screening was calculated as the difference between reported date of US arrival (regardless of visa status) and the DCDOH registration date. For asylees not reporting a US arrival date-reporting was not required-the shortest (most conservative) possible time to screening was calculated as the difference between the date an asylee was granted asylum and the DCDOH registration date, plus the minimum 13 weeks required to process an asylum application (rarely processed this quickly; US Citizenship and Immigration Services, unpublished data). Health status indicators were chosen based on overseas refugee screening protocols and prior refugee studies. We assumed a refugee to asylee ratio of 1:4 and used the US prevalence reported in the literature for each health indicator to calculate the sample size needed to achieve 80% power to detect an odds ratio of ≥3 comparing asylees with refugees and comparing asylees with the US population.
Tuberculosis status was determined by the result of a completed tuberculin skin test (TST). Clinical data needed to select a cutoff for TST positivity (eg, recent exposure to tuberculosis) were available to screening physicians, who used standard clinical criteria to recommend latent tuberculosis treatment, but were not reported [11] . Therefore, results from 2 TST result cutoffs, ≥5 mm and ≥10 mm, were analyzed, and an individual was considered to have latent tuberculosis using the more conservative cutoff of ≥10 mm [12] . We examined an additional surrogate for latent tuberculosis-whether latent tuberculosis treatment was recommended by the screening physician. To avoid false-positive TST results due to childhood BCG vaccination, we conducted a stratified analysis by age group.
Hepatitis B serologic tests were ordered for all clients; human immunodeficiency virus (HIV) testing was conducted only if a client elected testing. HIV status was based only on confirmed serologic results. Hepatitis B status was based on presence of serum hepatitis B surface antibody (anti-HBs) and presence of hepatitis B surface antigen (HBsAg).
Each client had 1 stool ova and parasite (O&P) test. Blastocystis hominis is of unknown pathogenicity [13] and up to 90% of Entamoeba histolytica reported on O&P results can be nonpathogenic Entamoeba dispar [14] . We therefore categorized parasites into nonpathogenic (B. hominis and E. histolytica/E. dispar) vs pathogenic (Ascaris lumbricoides, Giardia lamblia, Trichuris trichiura, and hookworm) parasites.
Immunization histories were reviewed during medical screening using age-specific US Advisory Committee on Immunization Practices (ACIP) recommendations [15, 16] . We defined adults as persons aged ≥19 years for this indicator to match ACIP recommendations. Vaccinations were considered needed if they were inadequate or not previously documented. Data were available for analysis for hepatitis B, polio, measlesmumps-rubella (MMR), and diphtheria-tetanus-acellular pertussis (DTaP), tetanus-diphtheria-acellular pertussis (Tdap), or tetanus-diphtheria (Td) booster vaccinations among children, and MMR and Tdap (newly recommended in 2006) or Td vaccinations among adults.
Categorical variables were compared using CochranMantel-Haenszel statistics and χ 2 tests in bivariate analyses.
Logistic regression with backward elimination was used for multivariable analyses of statistically significant health indicators from bivariate analyses, controlling for plausible demographic factors from prior refugee studies and factors with P < .20 in bivariate analyses. Multicollinearity, interactions with asylee or refugee status, and model goodness of fit (Hosmer-Lemeshow test) were assessed. Medians of continuous variables were compared using the Wilcoxon rank sum test. Prevalence of health indicators in asylees were compared with US population prevalence from national communitybased studies [17] [18] [19] [20] [21] using a z test for one proportion. Only conditions with a >5% prevalence in asylees and refugees were included in the analyses. Listwise deletion was used in multivariable analyses. Statistical significance was defined as 2-tailed P < .05. Analyses were performed using SAS software version 9.2 (Cary, North Carolina).
RESULTS

From 1 September 2003 to 31 August 2007
, 961 asylees and 216 refugees were registered at DCDOH. Of these, 205 were excluded because they initially resettled in another US location or were family-sponsored asylees, and 193 did not complete the medical screening, leaving 630 (66%) asylees and 151 (70%) refugees for this study. Demographic characteristics and the proportion of asylees vs refugees did not differ by screening completion status. Age ranges for asylees and refugees were similar, but median ages differed (31 years vs 22 years; P < .001; Table 1 ). Children accounted for fewer asylees than refugees (17% vs 42%; P < .001). The majority of clients were male; the percentage did not differ between asylees and refugees. A greater percentage of asylees than refugees were married (52% vs 32%; P < .001), but a greater percentage of asylees had no immediate family, including spouses, in the United States (72% vs 26%; P < .001). Of the 781 asylees and refugees, 730 (93%) originated from Africa; 68% of asylees and 55% of refugees were from Ethiopia.
Less than 25% of data were missing for asylees and refugees for health status indicators, except for hepatitis B (41% and 42% missing, respectively) and voluntary HIV (90% and 81% missing). Persons missing hepatitis B results were more likely to be single and aged ≤20 years than those with results. Persons without HIV results were more likely to be asylee, female, and aged ≤5 than those with results.
The percentage of asylees and refugees with TST induration ≥5 mm (41% vs 38%, respectively) and latent tuberculosis (TST ≥10 mm, 39% vs 38%) did not differ (Table 2 ). In age groupstratified analyses, no difference in TST induration was noted between asylees and refugees. Although asylees trended toward greater odds of being recommended latent tuberculosis treatment than refugees, ( The percentage of clients tested with a positive HIV serology appeared greater among asylees (13%) than refugees (7%; power <80%; Table 2 ). Twenty-six percent of asylees and 18% of refugees had a positive anti-HBs serology, which did not differ significantly ( power ≥80%); none could have received a routine childhood hepatitis B vaccination based on their ages and year of vaccine introduction into their countries of origin [22] . The percentage of clients with a positive HBsAg serology appeared smaller among asylees (2%) than refugees (6%; power <80%).
The percentage of asylees and refugees who tested positive for nonpathogenic parasites (15% vs 11%, respectively) and pathogenic parasites (4% vs 2%) did not differ significantly (power ≥80%; Table 2 ). The need for at least 1 vaccination (80% vs 80%) and need for specific vaccinations among asylee and refugee adults did not differ ( power ≥80%). Vaccination needs among asylee and refugee children did not appear to differ ( power <80%).
Prevalence of latent tuberculosis, [20] HIV infection, [18] HBsAg positivity, [21] need for each of the childhood immunizations [17, 19] , and need for adult Tdap or Td [23] were all significantly higher than that of the US population ( power ≥80% for all indicators; Table 3 ). No US community-based nationwide estimates of intestinal parasite prevalence or adult MMR coverage were available.
For the 202 (32%) asylees who reported a US arrival date, the median time from US arrival to medical screening was 55 weeks, compared with 1 week for the 147 (97%) refugees who reported a US arrival date (P < .001). Within 12 weeks of US arrival, 98% of refugees were registered for screening compared with only 2% of asylees. Asylees continued to register for years, with 42 (21%) registering 2 or more years after US arrival. When the most conservative time to screening was calculated (likely a substantial underestimate) for asylees not reporting a US arrival date, the median time for asylees as a group was at least 20 weeks. Asylees reporting a US arrival date were more likely to be adult, single, and male than asylees who did not report an arrival date.
DISCUSSION
Asylees in DC have latent tuberculosis prevalence, intestinal parasite carriage, and adult vaccination needs that do not differ from those of refugees in DC, but asylees are typically screened more than a year later. Latent tuberculosis prevalence, childhood and adult vaccination needs, HIV seropositivity, and hepatitis B infection prevalence in DC asylees are all significantly greater than in the US population into which they are resettling. This includes school-aged children, of whom >80% required at least one vaccination. This study, which describes the infectious disease concerns among a US asylee population for the first time in the published literature, suggests that asylees in DC have substantial communicable disease concerns that, due to a delay in screening, may result in unnecessary suffering and risk of disease transmission to others.
Early screening for latent tuberculosis is particularly important in new arrivals to the United States, as active tuberculosis most commonly occurs in the first 5 years after arrival, [24, 25] and new arrivals can have high rates of multidrug-resistant tuberculosis [26] . The majority of tuberculosis disease in the United States now occurs among foreign-born persons, and the proportion is increasing [27] . New arrivals from subSaharan Africa and Southeast Asia, [26] who represent close to half of all US refugees [28] and most of the clients in this study, have tuberculosis disease rates as high as those of close contacts of tuberculosis patients in the United States [26] . Notably, more than one-third of the 80% of asylees receiving TST were judged to require latent tuberculosis treatment, a prevalence not far from the prevalence of latent tuberculosis among healthcare workers in high-incidence tuberculosis countries [29] . The similar (or possibly greater) need for latent tuberculosis treatment among asylees vs refugees, coupled with the increased likelihood of active tuberculosis within 5 years in recent arrivals, heightens the urgency to screen asylees as quickly as refugees. Reasons for the increased odds of latent tuberculosis treatment need among asylees vs refugees with TST ≥10 mm are unclear-the same clinicians conducted the screenings using standard treatment recommendation criteria, and prior documented treatment for latent tuberculosis was unlikely in either group. Presence of clinical considerations for treatment, however, such as risk of alcoholism or malnutrition, was not reported but could have had a limited contribution to the observed difference.
Earlier diagnosis of HIV and initiation of antiretroviral therapy leads to decreased morbidity, increased survival, and decreased transmission [30, 31] . Although HIV screening was removed in 2010 as a requirement for immigrants and refugees entering the United States, the CDC highly recommends HIV screening for refugees [32] , and our data suggest that asylees might also benefit from screening. Similarly, earlier diagnosis of active hepatitis B allows for prophylaxis of at risk contacts, including education and vaccination. The anti-HBs test results suggest that exposure to hepatitis B was likely similar among asylees and refugees, as prior hepatitis B vaccination was unlikely in both groups. Although early intestinal parasite treatment decreases morbidity and potential transmission, we found low prevalence of infection with pathogenic parasites. However, infection prevalence among asylees upon US arrival was likely underestimated because parasitic burden decreases with time [33] and only 1 stool specimen was collected; clinical diagnosis in the United States requires 3 stool specimens. The low infection prevalence of pathogenic parasites among refugees was likely a result of mass treatment with albendazole prior to US arrival, which began in 1999 [34] . Although not conducted in this study, serologic screening for chronic parasites with potentially severe sequelae, including Strongyloides and Schistosoma species, could also be important. Recent outbreaks of measles and pertussis in the United States due to undervaccination have highlighted the need to maintain timely and adequate vaccination coverage [35] [36] [37] . Asylees and refugees were undervaccinated against multiple infections, including measles and pertussis; delays in vaccination place asylees and the US population at risk. The results of this study suggest that asylees need to be medically screened as urgently as do refugees in DC, and a median 55-week delay is too long. The lengthy asylum process contributes substantially to this delay, which includes extensive preparation of an application often requiring legal help; application processing, which takes a median of 17-24 weeks (fiscal years 2005-2007; US Citizenship and Immigration Services, unpublished data); and possible cycles of appeals with immigration courts, which can take months to years. After receipt of asylum, additional delay can occur; asylees are often unaware they are eligible for screening, lack resources to find or attend a screening, do not speak English, or, particularly in the case of torture victims, have a fear of government. Even in jurisdictions such as DC where emergency Medicaid is available, coverage does not extend to routine screening, primary care, or mental health. Providing medical screening to asylum applicants as a requirement of the application process accesses potential asylees at the earliest opportunity, minimizing infectious disease transmission risk and potential sequelae. As with refugees, states should be notified of asylees resettling in their jurisdictions, to enable states to provide adequate support. The parties responsible for the cost need to be determined.
Although the proportion of DC asylees our study represents cannot be estimated, age, sex, and marital status among asylee participants were comparable with those in asylees nationwide [1] . However, a greater percentage of asylee participants were from Africa, [1] and based on refugee data, region of origin can affect prevalence of certain infections [38] . At minimum, because of the required application process for all US asylees, the long delay before screening is likely generalizable to other US asylee populations. The degree of missing data was substantial for some health status indicators, especially the serological indicators, which could be a result of concern with providing blood. Although the direction of bias is not known, refusal bias in HIV tends to underestimate rates of HIV positivity [39, 40] . Although vaccination needs of asylees and refugees might be overestimated because of lost documentation, the percentage of missing vaccinations among children aged 0-18 years was similar to that among children in Ethiopia, [22] which was the country of origin for the majority of study clients.
To fully understand the health challenges of asylees, studies among other US asylee populations should be undertaken. In DC and other jurisdictions, accessing asylees at the point of application cannot be accomplished through local means. National policy changes are likely needed to provide asylum applicants in the United States with a medical screening as part of the application process, similar to US refugees. Filling this gap in US policy will minimize delay to medical screening, which is critical to preventing unnecessary suffering and risk of important communicable diseases for both asylees and the US communities into which they resettle.
Notes
